DA Sutra 30X Tablet 4’s
DA Sutra 30X Tablet is used to treat premature ejaculation and erectile dysfunction in adult men. It contains Dapoxetine and Sildenafil which work by relaxing the blood vessels and improving blood flow to the penis.
₹264.00 Original price was: ₹264.00.₹180.00Current price is: ₹180.00.
Description
About DA Sutra 30X Tablet
DA Sutra 30X Tablet is used in the treatment of premature ejaculation and erectile dysfunction in adult men. Premature ejaculation is when a man ejaculates (orgasms) more quickly with less sexual stimulation than the man or his partner would like. This could lead to problems in a sexual relationship. Erectile dysfunction is the inability to keep a hard and erect penis suitable for sexual activity.
DA Sutra 30X Tablet contains Dapoxetine and Sildenafil. Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that increases the serotonin levels in the brain, thereby increasing the time to ejaculate and improving the control over ejaculation. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor and works by relaxing the blood vessels. It can improve blood flow to the penis and helps to get an erection when sexually stimulated.
Additional information
brand | Mape |
---|---|
form | Oral Granules |
frequency | 1 tablet daily |
strength | 100 MG/5ML |
Related products
-
+ wishlist+ compare
AB Phylline SR 200 Tablet 10’s
₹299.97Original price was: ₹299.97.₹272.70Current price is: ₹272.70.Add to cart -
+ wishlist+ compare
Romy Injection
₹3,985.00Original price was: ₹3,985.00.₹3,400.00Current price is: ₹3,400.00.Add to cart -
+ wishlist+ compare
AB Phylline Syrup 100 ml
₹193.05Original price was: ₹193.05.₹175.50Current price is: ₹175.50.Add to cart -
+ wishlist+ compare
Revital Men Complete Multivitamin, 60 Capsules
₹589.05Original price was: ₹589.05.₹535.50Current price is: ₹535.50.Add to cart -
+ wishlist+ compare
Tobaresp Mistpules 5 x 5 ml
₹2,665.00Original price was: ₹2,665.00.₹2,000.00Current price is: ₹2,000.00.Add to cart
Reviews
There are no reviews yet.